ANIP ANI PHARMACEUTICALS INC Management Changes 8-K Filing 2023 - Policy Amendment and Director Resignation ANI Pharmaceuticals amended its Insider Trading Policy to prohibit directors, officers, and employees from holding securities in a margin account or pledging them for a loan, and a director, Robert E. Brown, Jr., decided not to seek reelection due to the policy change.Get access to all SEC 8-K filings of the ANI PHARMACEUTICALS INC